Zuben E Sauna

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 10

Top Topics

Venous Thromboembolism

Inflammatory Response

Dendritic Cells

Top Venues

Nature communications

Scientific reports

PLoS computational biology

This page only lists publications with an associated author ORCID identifier.

Publications

Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Wojciech Jankowski, Stepan S Surov, Nancy E Hernandez, Atul Rawal, Marcos Battistel, Darόn I Freedberg, Mikhail V Ovanesov, Zuben E Sauna
Engineering and evaluation of FXa bypassing agents that restore hemostasis following Apixaban associated bleeding. Nature communications 15 (1) (2024)
Marisabel Rodriguez Messan, Osman N Yogurtcu, Joseph R McGill, Ujwani Nukala, Zuben E Sauna, Hong Yang
Mathematical model of a personalized neoantigen cancer vaccine and the human immune system. PLoS computational biology 17 (9) (2021)
Vijaya L Simhadri, Louis Hopkins, Joseph R McGill, Brian R Duke, Swati Mukherjee, Kate Zhang, Zuben E Sauna
Cas9-derived peptides presented by MHC Class II that elicit proliferation of CD4+ T-cells. Nature communications 12 (1) (2021)
Wojciech Jankowski, Joseph R McGill, H A Daniel Lagassé, Stepan Surov, Gary Bembridge, Campbell Bunce, Edward Cloake, Mark H Fogg, Katarzyna I Jankowska, Abdul Khan, Joseph Marcotrigiano, Mikhail V Ovanesov, Zuben E Sauna
Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue. Blood advances 3 (17) (2020)
Wojciech Jankowski, Yara Park, Joseph McGill, Eugene Maraskovsky, Marco Hofmann, Vincent P Diego, Bernadette W Luu, Tom E Howard, Roberta Kellerman, Nigel S Key, Zuben E Sauna
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products. Blood advances 3 (9) (2020)
Aikaterini Alexaki, Gaya K Hettiarachchi, John C Athey, Upendra K Katneni, Vijaya Simhadri, Nobuko Hamasaki-Katagiri, Puja Nanavaty, Brian Lin, Kazuyo Takeda, Darόn I Freedberg, Dougald M Monroe, Joseph R McGill, Robert Peters, Jacob M Kames, David D Holcomb, Ryan C Hunt, Zuben E Sauna, Amy Gelinas, Nebojsa Janjic, Michael DiCuccio, Haim Bar, Anton A Komar, Chava Kimchi-Sarfaty
Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies. Scientific reports 9 (1) (2019)
Amy S Rosenberg, Zuben E Sauna
Immunogenicity assessment during the development of protein therapeutics. The Journal of pharmacy and pharmacology 70 (5) (2017)
Zuben E Sauna, Jay N Lozier, Carol K Kasper, Chen Yanover, Timothy Nichols, Tom E Howard
The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics. Blood 125 (2) (2014)